Rational Engineering of Physicochemical Properties of Nanomaterials for Biomedical Applications with Nanotoxicological Perspectives

Overview

Journal Nano Converg

Specialty Biotechnology

Date 2017 Feb 14

PMID 28191411

Citations 66

Authors

P N Navya

Hemant Kumar Daima

Affiliations

Soon will be listed here.

Abstract

Innovative engineered nanomaterials are at the leading edge of rapidly emerging fields of nanobiotechnology and nanomedicine. Meticulous synthesis, unique physicochemical properties, manifestation of chemical or biological moieties on the surface of materials make engineered nanostructures suitable for a variety of biomedical applications. Besides, tailored nanomaterials exhibit entirely novel therapeutic applications with better functionality, sensitivity, efficiency and specificity due to their customized unique physicochemical and surface properties. Additionally, such designer made nanomaterials has potential to generate series of interactions with various biological entities including DNA, proteins, membranes, cells and organelles at nano-bio interface. These nano-bio interactions are driven by colloidal forces and predominantly depend on the dynamic physicochemical and surface properties of nanomaterials. Nevertheless, recent development and atomic scale tailoring of various physical, chemical and surface properties of nanomaterials is promising to dictate their interaction in anticipated manner with biological entities for biomedical applications. As a result, rationally designed nanomaterials are in extensive demand for bio-molecular detection and diagnostics, therapeutics, drug and gene delivery, fluorescent labelling, tissue engineering, biochemical sensing and other pharmaceuticals applications. However, toxicity and risk associated with engineered nanomaterials is rather unclear or not well understood; which is gaining considerable attention and the field of nanotoxicology is evolving promptly. Therefore, this review explores current knowledge of articulate engineering of nanomaterials for biomedical applications with special attention on potential toxicological perspectives.

Citing Articles

Comprehensive analysis of electrochemical biosensors for early ovarian cancer detection.

El-Gammal M, Sayed F, Allam N RSC Adv. 2024; 14(50):37580-37597.

PMID: 39588243 PMC: 11587864. DOI: 10.1039/d4ra05972g.

Advances in hybridized nanoarchitectures for improved oro-dental health.

Guo J, Wang P, Li Y, Liu Y, Ye Y, Chen Y J Nanobiotechnology. 2024; 22(1):469.

PMID: 39113060 PMC: 11305065. DOI: 10.1186/s12951-024-02680-5.

Unleashing the promise of emerging nanomaterials as a sustainable platform to mitigate antimicrobial resistance.

Rahman S, Sadaf S, Hoque M, Mishra A, Mubarak N, Malafaia G RSC Adv. 2024; 14(20):13862-13899.

PMID: 38694553 PMC: 11062400. DOI: 10.1039/d3ra05816f.

Introduction into nanotechnology and microbiology.

Ball A, Patil S, Soni S Methods Microbiol. 2024; 46:1-18.

PMID: 38620196 PMC: 7148861. DOI: 10.1016/bs.mim.2019.04.003.

Bioactive silver nanoparticles fabricated using Lasiurus scindicus and Panicum turgidum seed extracts: anticancer and antibacterial efficiency.

Alburae N, Alshamrani R, Mohammed A Sci Rep. 2024; 14(1):4162.

PMID: 38378923 PMC: 10879090. DOI: 10.1038/s41598-024-54449-3.

References

Longmire M, Choyke P, Kobayashi H . Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond). 2008; 3(5):703-17. PMC: 3407669. DOI: 10.2217/17435889.3.5.703. View

McNeil S . Nanotechnology for the biologist. J Leukoc Biol. 2005; 78(3):585-94. DOI: 10.1189/jlb.0205074. View

Duncan R, Gaspar R . Nanomedicine(s) under the microscope. Mol Pharm. 2011; 8(6):2101-41. DOI: 10.1021/mp200394t. View

Oberdorster G, Oberdorster E, Oberdorster J . Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005; 113(7):823-39. PMC: 1257642. DOI: 10.1289/ehp.7339. View

Kang S, Herzberg M, Rodrigues D, Elimelech M . Antibacterial effects of carbon nanotubes: size does matter!. Langmuir. 2008; 24(13):6409-13. DOI: 10.1021/la800951v. View

Dykman L, Khlebtsov N . Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev. 2011; 41(6):2256-82. DOI: 10.1039/c1cs15166e. View

Ozay O, Akcali A, Tatman Otkun M, Silan C, Aktas N, Sahiner N . P(4-VP) based nanoparticles and composites with dual action as antimicrobial materials. Colloids Surf B Biointerfaces. 2010; 79(2):460-6. DOI: 10.1016/j.colsurfb.2010.05.013. View

Sanvicens N, Marco M . Multifunctional nanoparticles--properties and prospects for their use in human medicine. Trends Biotechnol. 2008; 26(8):425-33. DOI: 10.1016/j.tibtech.2008.04.005. View

Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H . Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A. 2007; 104(7):2050-5. PMC: 1892985. DOI: 10.1073/pnas.0608582104. View

10.

Freitas Jr R . What is nanomedicine?. Nanomedicine. 2007; 1(1):2-9. DOI: 10.1016/j.nano.2004.11.003. View

11.

Salata O . Applications of nanoparticles in biology and medicine. J Nanobiotechnology. 2004; 2(1):3. PMC: 419715. DOI: 10.1186/1477-3155-2-3. View

12.

Kawata K, Osawa M, Okabe S . In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol. 2009; 43(15):6046-51. DOI: 10.1021/es900754q. View

13.

Suh W, Suslick K, Stucky G, Suh Y . Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol. 2008; 87(3):133-70. PMC: 2728462. DOI: 10.1016/j.pneurobio.2008.09.009. View

14.

Daima H, Selvakannan P, Kandjani A, Shukla R, Bhargava S, Bansal V . Synergistic influence of polyoxometalate surface corona towards enhancing the antibacterial performance of tyrosine-capped Ag nanoparticles. Nanoscale. 2013; 6(2):758-65. DOI: 10.1039/c3nr03806h. View

15.

Zhao J, Castranova V . Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B Crit Rev. 2011; 14(8):593-632. DOI: 10.1080/10937404.2011.615113. View

16.

Partha R, Conyers J . Biomedical applications of functionalized fullerene-based nanomaterials. Int J Nanomedicine. 2009; 4:261-75. PMC: 2789438. View

17.

Euliss L, DuPont J, Gratton S, DeSimone J . Imparting size, shape, and composition control of materials for nanomedicine. Chem Soc Rev. 2006; 35(11):1095-104. DOI: 10.1039/b600913c. View

18.

Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y . Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small. 2011; 7(10):1322-37. DOI: 10.1002/smll.201100001. View

19.

Lok C, Ho C, Chen R, He Q, Yu W, Sun H . Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem. 2007; 12(4):527-34. DOI: 10.1007/s00775-007-0208-z. View

20.

Bunz U, Rotello V . Gold nanoparticle-fluorophore complexes: sensitive and discerning "noses" for biosystems sensing. Angew Chem Int Ed Engl. 2010; 49(19):3268-79. DOI: 10.1002/anie.200906928. View